Magic Hour
You are here:  Home  >  Biotech  >  Current Article

Stellar stock soars after shareholders OK deal with Edesa

By   /   Friday, May 31st, 2019  /   Comments Off on Stellar stock soars after shareholders OK deal with Edesa

    Print       Email
Stellar Biotechnologies shares shot up more than 60 percent May 31 after the company’s shareholders approved a deal with Canadian therapeutics firm Edesa Biotech that could see it wind down its Port Hueneme operations. The deal leaves current Stellar shareholders with a 10 percent interest in Edesa, while Edesa investors retain the other 90 percent,…


    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.
    Print       Email

You might also like...

Carpinteria-based Procore Technologies moved up from No. 880 last year to No. 697 this year. (Nik Blaskovich)

Procore announces second recent acquisition

Read More →